Section VI：Probiotics,Prebiotics and Postbiotics - Session 2：Clinical Efficacy and Activity-Based Standards：Elevating Probiotic Quality |
2027-02-24 09:00-11:30 |
| |
| 2027-02-24 09:00-09:20 Reconstruction of High-Activity Probiotic Standards Based on Clinical Evidence |
| 2027-02-24 09:20-09:40 Research and Application of Whole-Chain Quality Assurance Technologies for Probiotic ViabilityDr. Yang Jiasen,Senior R&D Manager,Weikan Probiotics (Suzhou) Co.,Ltd. |
| 2027-02-24 09:40-10:00 Bifidobacterium animalis subsp. lactis BLa80:Research and Translation of a Strain Safeguarding Infant and Toddler Health |
| 2027-02-24 10:00-10:20 Spore-Forming Probiotic BC99:Multi-Dimensional Health Regulation Based on Multi-Target Mechanisms |
| 2027-02-24 10:20-10:40 TBCTBC |
| 2027-02-24 10:40-11:30 Roundtable:R&D Strategies for High-Activity Quality Probiotic Strains Based on Clinical Evidence |
